-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
-
Summary
-
Silence Therapeutics plc quarterly/annual Net Cash Provided by (Used in) Financing Activities history and change rate from 2022 to Q1 2025.
- Silence Therapeutics plc Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2025 was $14K.
- Silence Therapeutics plc annual Net Cash Provided by (Used in) Financing Activities for 2024 was $142M, a 345% increase from 2023.
- Silence Therapeutics plc annual Net Cash Provided by (Used in) Financing Activities for 2023 was $31.9M, a 39.3% decline from 2022.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)